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Abstract Since the conserved near N-terminal region (residues 
18-37) of chromogranin A (CGA) has tentatively been identified 
as the vesicle membrane interacting region using synthetic 
peptides, it was necessary to confirm this finding with CGA 
deletion proteins. In order to address this need and to clarify the 
discrepancies of the published amino acid sequences of CGA, we 
cloned a CGA gene and produced CGA deletion proteins of 
various sizes. The recombinant CGA protein lacking the first 16 
amino acid residues bound to the vesicle membrane as well as the 
full-length CGA at pH 5.5. However, the CGA protein lacking 
the first 39 amino acid residues, which include the conserved near 
N-terminal region (residues 17-38), failed to interact with the 
vesicle membrane at pH 5.5, clearly indicating the essential role 
of the conserved near N-terminal region in the pH-dependent 
interaction of CGA with the vesicle membrane. 
© 1997 Federation of European Biochemical Societies. 
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1. Introduction 
Chromogranin A, one of the major proteins of the secretory 
vesicles of neuroendocrine cells [1,2], is known to interact with 
several other integral membrane proteins of secretory vesicles 
at p H 5.5 and dissociated from them at p H 7.5 [3]. Further-
more, several secretory vesicle matrix proteins bound to C G A 
at p H 5.5 and dissociated from it at p H 7.5 [4]. In addition to 
the acidic pH-dependent membrane binding property of C G A 
[5], chromogranin A has been shown to undergo pH- and 
Ca 2 + -dependent aggregation [6,7] and conformational changes 
[7], more readily aggregating at p H 5.5 than at p H 7.5 in the 
presence of Ca 2 + . The acidic pH- and Ca 2 +- induced aggrega-
tion of C G A at p H 5.5, along with its binding to the vesicle 
membrane [5] and interaction with other vesicular matrix pro-
teins [4], strongly suggested important roles of C G A in secre-
tory vesicle biogenesis. 
In our previous study, it was shown that a synthetic peptide 
representing the near N-terminal region of CGA, residues 18-
37 ( IVEVISDTLSKPSPMPVSKE, in single letter code), inter-
acted with the secretory vesicle membrane at p H 5.5 and dis-
sociated from it at p H 7.5 [5], raising the possibility that this 
conserved near N-terminal region of C G A may be its mem-
brane binding anchor region. N o other peptides representing 
various other regions of CGA, including the conserved C-ter-
minal region, appeared to interact with the vesicle membrane 
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[5]. Since the interaction of the near N-terminal region of 
C G A with the vesicle membrane was shown by a synthetic 
peptide, there was a need to confirm the suggested role of the 
conserved near N-terminal region of C G A in the interaction 
with the vesicle membrane using truncated C G A proteins. In 
order to identify the membrane interacting region of C G A 
and to clarify the discrepancies of the published amino acid 
sequences of chromogranin A [8-10], we have cloned a bovine 
C G A gene and generated several different length recombinant 
C G A proteins. Using the purified recombinant C G A proteins, 
we now show that the conserved near N-terminal region of 
C G A is essential for C G A binding to the vesicle membrane. 
2. Materials and methods 
2.1. Library screening and sequencing 
Approximately 2X105 plaques from the bovine adrenal medullar 
cDNA library were screened using a bovine chromogranin A probe 
obtained by PCR amplification using oligonucleotide primers 5'-
AGGGGAAGGGGGAGTGGGCA-3' and 5'-TTAGATAAAGCT-
TCATACACA-3'. The nucleotide sequences of both strands of the 
chromogranin A clone were determined. 
2.2. Construction of CGA clones and subcloning into expression vector 
In order to construct the CGA clones, PCR was used to add a 
BamHl site to the 5'-end and a HindUl site to the 3'-end of each 
chromogranin A clone. After the PCR products were digested with 
BamHl and HindUl, each of the CGA clones was subcloned into 
pET28a(+) (obtained from Novagen) digested with BamHl and Hin-
dUl previously. The correct size and proper orientation were con-
firmed by determining the nucleotide sequence of each CGA clone. 
The pET28a(+) vector carries an N-terminal His tag (a stretch of six 
His) to which nickel binds tightly. 
2.3. Expression and Ni-NTA agarose affinity chromatography 
E. coli BL21(DE3) was used as the host for expression. Initial 
purification of various deletion protein products of CGA was per-
formed using nickel-nitrilotriacetic acid (Ni-NTA) agarose affinity 
chromatography from Qiagen. 
2.4. Purification of recombinant CGA proteins 
In order to further purify the recombinant CGA proteins phenyl-
Sepharose column chromatography or phenyl-Sepharose chromatog-
raphy followed by DE-52 column chromatography was employed as 
described below for each protein. The phenyl-Sepharose column (2.5 
cm X 8.5 cm) was equilibrated with 15 mM Tris-HCl, pH 7.5, 0.2 mM 
CaCl2, 0.25 M ammonium sulfate, and a reverse ammonium sulfate 
gradient was used to elute the proteins. The DE-52 column (2.5 cmX7 
cm) was equilibrated with 10 mM imidazole, pH 6.1, and KC1 gra-
dients were used to elute the proteins. The chromatographic proce-
dures and buffers used for each recombinant protein purification were 
as follows: (1) recombinant CGA (rCGA) 1-431; the Ni-NTA col-
umn eluate was loaded onto the phenyl-Sepharose column, washed 
with 0.1 M ammonium sulfate (wash I) and 50 mM ammonium sul-
fate buffer (wash II), and eluted with a reverse gradient ammonium 
sulfate (50 mM-0 M) buffer. Additional buffer (15 mM Tris-HCl, pH 
7.5. 0.2 mM C a C y without ammonium sulfate was added at the end 
of the gradient to complete the elution. Appropriate pools from the 
phenyl-Sepharose column chromatography were loaded onto the DE-
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52 column, washed with 0.15 M KC1 buffer, and eluted with a KC1 
gradient of 0.15 M-0.35 M. (2) rCGA 1-231; the eluted proteins from 
the Ni-NTA column were loaded onto the phenyl-Sepharose column, 
washed with 0.2 M ammonium sulfate buffer (wash I) and 0.1 M 
ammonium sulfate buffer (wash II), and eluted with a reverse gradient 
ammonium sulfate (0.1 M-0 M) buffer. Additional buffer without 
ammonium sulfate was added at the end of the gradient to complete 
the elution. (3) rCGA 232-431; the Ni-NTA column eluate was 
loaded onto the phenyl-Sepharose column, and the rCGA 232—131 
was eluted with 0.1 M ammonium sulfate buffer. (4) rCGA 17^431; 
purification of rCGA 17—431 followed the same steps as for rCGA 1-
431 purification except that the pooled fractions from the first DE-52 
step were rechromatographed on the same DE-52 column equilibrated 
with 0.2 M KC1 buffer. Elution of the second DE-52 column was 
carried out with a KC1 gradient of 0.2 M-0.3 M. (5) rCGA 40-431; 
purification of rCGA 40^131 followed the same steps as for rCGA 1-
431 purification. 
2.5. Coupling the secretory vesicle membrane to cyanogen bromide 
(CNBr)-Sepharose 4B 
Coupling of the vesicle membrane to the CNBr-activated Sepharose 
4B was done as described previously [5]. 
3. Results 
Bovine chromogranin A had previously been cloned and 
sequenced by three other groups [8-10]. However, they dif-
fered from each other in nine amino acid residues out of 431 
residues (Fig. 1). In view of these differences between the 
clones and considering the importance of the establishment 
of the correct amino acid sequence of CGA, we have cloned 
and sequenced a bovine CGA. As shown in Fig. 1, our se-
quence agreed with the published sequences except for 10 
amino acid residues. Interestingly, nine of these 10 residues 
are in the same locations where the amino acids differed from 
each other among the three published sequences (Fig. 1). 
However, at residue 275 our sequence contained serine where 
the two other sequences contained alanine. Although several 
differences in sequence were observed among the four sequen-
ces, no sequence variation was observed in the conserved near 
N-terminal region (residues 17-38), the calmodulin binding 
region (residues 40-65) [11], and the conserved C-terminal 
region (residues 407^131). Given the complete sequence iden-
tity of these essential regions and considering the fact that 
only one clone differed from the other three clones in all the 
positions with different amino acid residues (Fig. 1), the slight 
differences in sequence may be a reflection of polymorphism 
of the CGA gene. 
Fig. 2 shows the size of recombinant CGA fragments gen-
erated and the purity of the purified CGA proteins used in the 
vesicle membrane binding experiments. Since a peptide repre-
senting the conserved near N-terminal region (residues 18-37) 
of CGA had been demonstrated previously to bind to the 
1 94 118 136 137 141 275 293 301 361 373 431 
I: Q S S P--P A--H--K G--Q 
2: Q F P C—-A A--R--E G--R 
3: T F S P--P A—R--E R--R 
4: Q F S P--P S--R--E G--R 
(AAC) (TIT) (TCCCCAXCCG) (TCA)(CGT)(GAG) (GGG)[CGG) 
Fig. 1. Alignment of the deduced amino acid sequences of bovine 
chromogranin A with published sequences. Sequence #1 is that of 
Benedum et al. [8], sequence #2 is that of Iacangelo et al. [9], se-
quence #3 is that of Ahn et al. [10], and sequence #4 is our se-
quence. Identical sequences are shown by short lines while the posi-
tion and identity of the different amino acid residues are indicated 
by position numbers on top of the different residues (in single letter 
code). The nucleotide sequences in parentheses indicate the nucleo-
tide sequences of #4 corresponding to the different amino acid resi-
dues shown. 
Fig. 2. Size and SDS-PAGE of the purified recombinant CGA pro-
teins. A: Various sizes of the recombinant CGA proteins generated: 
(1) rCGA 1^131, (2) rCGA 1-231, (3) rCGA 232-431, (4) rCGA 
17-131, (5) rCGA 40^131. B: SDS-PAGE of the five purified rCGA 
proteins: (1) rCGA 1-131, (2) rCGA 1-231, (3) rCGA 232^131, (4) 
rCGA 17-131, (5) rCGA 40-431. 
secretory vesicle membrane at pH 5.5 [5], proteins 4 (rCGA 
17^131) and 5 (rCGA 40^4-31) were constructed without the 
first 16 amino acids and without the first 39 amino acids, 
respectively. 
Purified rCGA 1—431 was eluted in gel filtration chroma-
tography in a volume indicative of a protein with a molecular 
mass of ~330 kDa (S.H. Yoo, unpublished result) compared 
to ~300 kDa shown with natural CGA [7,12], suggesting a 
similar physical state between rCGA 1—431 and natural CGA. 
To determine whether the purified recombinant CGA proteins 
can bind to the vesicle membrane at the intravesicular pH of 
5.5, 80 |a.g of each rCGA protein was applied to the vesicle 
membrane-coupled Sepharose 4B column (0.5 ml volume) 
equilibrated with 20 mM sodium acetate, pH 5.5, 4 mM 
EGTA, 0.1 M KC1 (Fig. 3). Then the column was washed 
with 0.1 M KC1 (wash I), 1 M KC1 (wash II), and again 
with 0.1 M KC1 (wash III), all in 20 mM sodium acetate, 
pH 5.5, 4 mM EGTA. After thorough washes the pH of the 
elution buffer was changed to 7.5. As shown in Fig. 3, a pH 
7.5/1 M KC1 buffer released a large amount of protein from 
the column that had been loaded with rCGA 1^431 proteins 
and washed thoroughly, apparently indicating that the change 
of pH from 5.5 to 7.5 caused the dissociation of the bound 
proteins. The fractions eluted from the column were analyzed 
by SDS-PAGE. As shown in Fig. 4, a significant amount of 
rCGA 1—431 was present in the fractions eluted with the pH 
7.5/1 M KC1 buffer. This result indicated that rCGA 1^131 
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Fig. 3. Vesicle membrane-coupled Sepharose 4B chromatography of 
recombinant chromogranin A 1^431. 80 ug of rCGA 1-431 in 4 ml 
of 20 mM sodium acetate, pH 5.5, 4 mM EGTA, 0.1 M KC1 was 
loaded onto a vesicle membrane-coupled Sepharose 4B column (0.5 
ml vol) equilibrated with 20 mM sodium acetate, pH 5.5, 4 mM 
EGTA, 0.1 M KC1. The column was washed with 0.1 M KC1 (wash 
I), followed by 1.0 M KC1 (wash II) and 0.1 M KC1 (wash III), all 
in 20 mM sodium acetate, pH 5.5, 4 mM EGTA. After the washes, 
the rCGA 1-431 was eluted with a pH 7.5 buffer (20 mM Tris-HCl, 
pH 7.5, 4 mM EGTA, 1 M KC1). The fraction size was 0.8 ml/frac-
tion for the washes and 0.4 ml/fraction for elution, and the chroma-
tography was carried out at room temperature. 
bound to the vesicle membrane at pH 5.5 and was released 
from it at pH 7.5. 
The amounts of other rCGA proteins bound to the vesicle 
membrane column are summarized in Table 1. Out of 80 ug 
of each rCGA protein loaded, 17 ug of rCGA 1^431 and 12 
ug of rCGA 17-431 bound to the column compared to < 2 u.g 
of rCGA 4(M31 (Table 1). The loading and elution of rCGA 
1-231 and rCGA 232^431 proteins showed that only a limited 
amount of rCGA 1-231 (6 ug) bound to the column while 
virtually no rCGA 232-431 ( < 1 ug) bound to the column 
(Table 1). Although rCGA 1-231 was expected to bind well 
to the vesicle membrane, the lower than expected binding of 
rCGA 1-231 to the vesicle membrane suggests that the C-
terminal half of the molecule is also important in supporting 
the interaction of the near N-terminal anchor region with the 
vesicle membrane. 
4. Discussion 
Chromogranin A [8-10,13-17] has two conserved regions, 
which are shared by chromogranin B [18-21], one being the 
near N-terminal region (residues 17-38) and the other being 
the C-terminal region (residues 407^-31), implying important 
functional roles of these two regions. The present results iden-
tify the conserved near N-terminal region as the membrane 
binding anchor region of CGA, consistent with the previous 
results obtained with synthetic CGA peptides [5]. According 
to the hydrophobicity plot of CGA [8], this near N-terminal 
region including the two flanking cysteine residues stands out 
as the most hydrophobic region in the entire molecule. In this 
respect, the membrane binding anchor role of this hydropho-
bic region might have contributed to the conservation of the 
sequences in this region. 
In spite of the fact that chromogranin A interacts with the 
vesicle membrane proteins through its conserved near N-ter-
minal region, the recombinant CGA 1-231 protein that con-
Fig. 4. SDS-PAGE of the eluted proteins from the vesicle mem-
brane-coupled Sepharose 4B chromatography. The eluted rCGA 1-
431 fractions were diluted 5-fold with water to reduce the salt con-
centration and concentrated 25-fold using Centricon-10 (Amicon, 
Beverly, MA). 25 JJ.1 aliquots of these are analyzed on a 10% SDS-
polyacrylamide gel. Lane a: pre-loading rCGA 1^ 431 (1 ug); lanes 
b, c, and d: fractions 1, 2, and 3. Intact rCGA 1—431 is indicated 
by an arrow. 
tained the N-terminal half of the molecule did not bind the 
vesicle membrane as well as the intact CGA, rCGA 1^431 
(Table 1). This result suggests that the C-terminal half of 
the molecule might provide a structural stability of the whole 
molecule, thus facilitating the proper interaction of the near 
N-terminal region with the vesicle membrane. In this regard, 
the failure of the C-terminal half of the molecule to interact 
with the vesicle membrane did not come as a surprise. Since 
the conserved C-terminal region (residues 407^131) had been 
suggested to be primarily responsible for dimerization and 
tetramerization of CGA [22], it appeared to be a natural con-
sequence that the C-terminal region failed to interact with the 
vesicle membrane. 
Table 1 
Summary of the vesicle membrane-coupled Sepharose 4B chroma-
tography of recombinant CGA proteins" 
rCGA 
1^131 
1-231 
232-431 
17^131 
40-431 
Flow-through 
(ug) 
15 
27 
26 
15 
28 
Washes 
(ug) 
48 
47 
53 
53 
50 
Eluted 
(ug) 
17 
6 
< 1 
12 
< 2 
a80 ug of each CGA protein was loaded and the chromatography was 
carried out as described in Fig. 3. 
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In addition to the pH-induced conformational changes, 
chromogranin A has been known to interact with several 
vesicle membrane proteins including the inositol 1,4,5-tri-
sphosphate receptor at the intravesicular pH of 5.5 and to 
dissociate from them at a near physiological pH of 7.5 [3]. 
The pH-dependent interaction of CGA with the vesicle mem-
brane proteins was considered a pivotal step in the sorting 
process of both the vesicle matrix proteins and the membrane 
proteins during vesicle biogenesis [3]. Although it has gener-
ally been considered that the acidic pH- and Ca2+-induced 
aggregation of vesicle matrix proteins is the first step of selec-
tive segregation of these vesicle matrix proteins of regulated 
secretory pathways [23,24], the question of how this vesicle 
matrix complex binds to the potential vesicle membrane in 
the trans-Golgi network and eventually ends up in the secre-
tory vesicles is not well understood. Nevertheless, working 
with purified CGA and the secretory vesicle membrane, we 
have demonstrated that the acidic pH is the necessary and 
sufficient condition to cause CGA and the vesicle matrix pro-
tein aggregate to bind to the vesicle membrane [5], the key 
step in the sorting of vesicle matrix proteins and the vesicle 
membrane. In this respect, the identity of the conserved near 
N-terminal region as the anchor for CGA interaction with the 
vesicle membrane provides further insight into the protein 
sorting mechanism during secretory vesicle biogenesis. 
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